Latest Health News
WHO Expresses Regret Over US Withdrawal from Organization
The World Health Organization has formally regretted the United States' withdrawal, warning it weakens global and national health security amid rising threats. WHO highlighted US contributions to achievements like smallpox eradication and defended its COVID-19 response, including early alerts and guidance.
The decision will be reviewed by WHO’s Executive Board on February 2 and World Health Assembly in May 2026.
US Officially Exits WHO, Signaling Shift in Global Health Policy
The US departure from WHO became official in late January 2026 under the Trump administration, citing issues with COVID-19 response and lack of accountability. As WHO's largest funder, the exit prompts 2,300 job cuts and downsizing of divisions by summer 2026.
Experts warn it undermines global cooperation on diseases like Ebola, mpox, and influenza.
20-Year Follow-Up Shows 100% Survival in Breast Cancer Vaccine Trial
A breast cancer vaccine trial follow-up reveals 100% of participants with metastatic disease alive after 20 years, linked to CD4+ T cells and CD27 marker. Lab studies in mice showed combining vaccine with CD27 signaling eliminated tumors in most cases.
This could breakthrough cancer vaccine effectiveness.
Statin Muscle Pain Mechanism Identified, Paving Way for Safer Drugs
Researchers found statins cause muscle pain by binding to ryanodine receptor (RyR1), opening calcium channels and causing toxic leaks. This discovery offers a roadmap for developing drugs without these side effects.
It addresses a common issue limiting statin use for heart disease prevention.
Sepsis Drug STC3141 Reduces Severity in Phase II Trial
Phase II trial of carbohydrate-based STC3141 reduced sepsis severity in 180 patients by preventing organ failure. Unlike symptom management, it targets disease progression directly.
This breakthrough could improve outcomes for this life-threatening condition.
Gut Bacteria Trick Turns into Anti-Aging Compound Factories
Low doses of antibiotic cephaloridine prompt gut bacteria to produce more colanic acid, extending lifespan in worms and improving metabolism in mice. The drug acts only in the gut, avoiding systemic side effects.
This approach could lead to new longevity-promoting medicines via microbiota.
World NTD Day 2026 Calls for Action to Eliminate Neglected Tropical Diseases
On World NTD Day under theme 'Unite. Act. Eliminate.', WHO urges sustained funding as 58 countries eliminated at least one NTD, targeting 100 by 2030. In Yemen, diseases like leishmaniasis persist amid conflict, but progress shows elimination possible.
Funding cuts risk resurgence and threaten vulnerable communities.
New Prostate Cancer Treatment Listed on Australia's PBS
Australia lists a new treatment for metastatic prostate cancer on PBS from February 1, 2026, making it affordable at $7.70 for concessional patients. Prostate cancer affects 1 in 5 men, with 30,000 new cases yearly; early detection has high survival but metastatic cases challenge.
This supports nearly 300,000 living with the disease.
Glioblastoma Treatment Breakthrough via miR-181d Stabilization
Brown University researchers identified miR-181d regulating tumor cell variability, improving chemotherapy response in aggressive brain cancer. Stabilizing this molecule via gene therapy enhances uniform tumor cell response.
It addresses resistance from intra-tumor differences.
Lung Cancer Surgery Needs More Lymph Node Checks for Accuracy
2026 Society of Thoracic Surgeons Meeting research shows additional lymph node evaluation during non-small cell lung cancer surgery identifies spread better. This improves staging and treatment decisions.
It highlights need for thorough intraoperative assessment.
Reprogramming Tumor Immune Cells to Fight Cancer
Scientists used a drug to reprogram macrophages from tumor-protecting to cancer-killing cells. This reverses how tumors hijack immune response.
It offers new immunotherapy potential.
SGLT2 Inhibitors Preserve Kidney Function in Aging Models
Using fast-aging killifish, diabetes drugs SGLT2 inhibitors reduced kidney inflammation and preserved structure/function. This suggests benefits for age-related kidney decline.
It expands applications beyond diabetes.